Digestive system neuroendocrine neoplasm
Clinical trials for Digestive system neuroendocrine neoplasm explained in plain language.
Never miss a new study
Get alerted when new Digestive system neuroendocrine neoplasm trials appear
Sign up with your email to follow new studies for Digestive system neuroendocrine neoplasm, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to shrink Hard-to-Treat carcinoid tumors
Disease control OngoingThis Phase II trial tests whether combining lenvatinib and everolimus can shrink or slow advanced carcinoid tumors that cannot be removed by surgery. The study enrolls 36 adults with confirmed unresectable carcinoid tumors. Both drugs are taken orally and work by blocking enzymes…
Matched conditions: DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New Vaccine-Chemo combo shows promise for Tough-to-Treat tumors
Disease control PausedThis study tests whether adding a vaccine called SurVaxM to the chemotherapy drug temozolomide can help control advanced neuroendocrine tumors that are growing. About 60 adults with these rare cancers will receive either the combination or chemo alone. The goal is to see if the v…
Matched conditions: DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC